Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
HALO
PEN
Add up to 3 more stocks
HALO
Halozyme Therapeutics, Inc.
+0.74%
$109.11+0.80Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$12.94B
52W Range
$61.23 - $116.85
PEN
Penumbra, Inc.
+0.21%
$317.78+0.67Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$12.52B
52W Range
$221.26 - $362.41
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 32.57 | 78.08 |
| Forward P/E | 12.97 | 67.50 |
| PEG Ratio | 1.42 | N/A |
| P/B Ratio | 90.16 | 8.18 |
| P/S Ratio | 7.78 | 8.32 |
| P/FCF Ratio | 16.05 | 57.98 |
| EV/EBITDA | 14.15 | 61.25 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 78.2% | 67.8% |
| Operating Margin | 56.8% | 12.4% |
| Net Margin | 24.9% | 10.7% |
| ROE | 288.1% | 10.5% |
| ROA | 16.1% | 8.1% |
| ROIC | 27.4% | 8.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.71 | 5.75 |
| Quick Ratio | 2.31 | 3.86 |
| Debt/Equity | 14.95 | 0.14 |
| Interest Coverage | 45.03 | 144.35 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.